Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomised Trial Investigating the Benefits of the Addition of Modulated Electro-hyperthermia to Chemo-radiation for Cervical Cancer in HIV Positive and Negative Women in South Africa

NCT03332069 is registered in ClinicalTrials.gov with Jeffrey Kotzen as lead sponsor.

NCT NCT03332069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03332069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomised Trial Investigating the Benefits of the Addition of Modulated Electro-hyperthermia to Chemo-radiation for Cervical Cancer in HIV Positive and Negative Women in South Africa
Lead sponsor
Jeffrey Kotzen
Phase
Phase 3
Overall status
Unknown status
Start date
January 9, 2014
Completion date
July 31, 2020
Enrollment
236 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer